Clinical use of ultrasensitive cardiac troponin I assay in intermediate- and high-risk surgery patients.
Borges, Flávia Kessler; Furtado, Mariana Vargas; Rossini, Ana Paula Webber; Bertoluci, Carolina; Gonzalez, Vinícius Leite; Bertoldi, Eduardo Gehling; Pezzali, Luíza Guazzeli; Machado, Daniel Luft; Grutcki, Denis Maltz; Rech, Leandro Gazziero; Magalhães, Mariana; Polanczyk, Carisi Anne.
; 35(6): 945-53, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24489430
Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).
Effects of non-invasive remote ischemic conditioning on rehabilitation after myocardial infarction.
Mending a Faltering Heart.
Ultrasound-targeted microbubble destruction enhances delayed BMC delivery and attenuates post-infarction cardiac remodelling by inducing engraftment signals.
Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study.
Long-Range Surface Plasmon-Polariton Waveguide Biosensors for Human Cardiac Troponin I Detection.
[THE DIAGNOSTIC AND THERAPEUTIC CHALLENGE OF TYPE 2 MYOCARDIAL INFRACTION].
Discrimination of patients with type 2 myocardial infarction.
Cardiac troponin I associated with the development of unrecognized myocardial infarctions detected with MRI.